Skip to main content
Figure 1 | BMC Biotechnology

Figure 1

From: Selective targeted delivery of the TNF-alpha receptor p75 and uteroglobin to the vasculature of inflamed tissues: a preliminary report

Figure 1

L19-hUG-TNFRII characterization. A) Scheme of the cDNA of L19-UG-TNFRII including the leader peptide; CMV cytomegalovirus promoter. B) Schematic representation of homodimeric L19-UG-TNFRII. C) SDS-PAGE analysis of purified L19-UG-TNFRII under reducing (R) and non-reducing (NR) conditions; on the left the molecular masses of the standards in kDa. D) Size exclusion chromatography profile (Superdex 200) of purified L19-UG-TNFRII; mAU, milli-absorbance units.

Back to article page

BMC Biotechnology

ISSN: 1472-6750

Contact us